Name: Circulating Tumor Cells in Breast Cancer Metastatic Disease (en Inglés)
Price: 570147.00 COP
Availability: InStock
Author: Piñeiro, Roberto
ISBN: 9783030358044

portada Circulating Tumor Cells in Breast Cancer Metastatic Disease (en Inglés)

Formato

Libro Físico

Editorial

Springer

Autor

Piñeiro, Roberto

Idioma

Inglés

N° páginas

167

Encuadernación

Tapa Dura

Dimensiones

25.9 x 19.6 x 1.3 cm

Peso

0.50 kg.

ISBN13

9783030358044

Categorías

Equipamiento y técnicas médicas
Oncología
Biología molecular

Circulating Tumor Cells in Breast Cancer Metastatic Disease (en Inglés)

Piñeiro, Roberto (Autor) · Springer · Tapa Dura

Libro Físico

$ 570.147

$ 950.245

Ahorras: $ 380.098

40% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Martes 30 de Julio y el Jueves 08 de Agosto.

Lo recibirás en cualquier lugar de Colombia entre 1 y 5 días hábiles luego del envío.

Reseña del libro "Circulating Tumor Cells in Breast Cancer Metastatic Disease (en Inglés)"

This book is aimed to summarise the key aspects of the role of circulating tumour cells (CTCs) in breast cancer, with special attention to their contribution to tumour progression and establishment of metastatic disease. We aim to give a clear overview of the knowledge about CTCs, framed in the context of breast cancer, by analysing basic and clinical research carried out so far. In a broader sense, we will address what are the main clinical needs of this disease based on its molecular heterogeneity (subtypes) and lay out the knowledge and understanding that CTCs are giving about it and how they are contributing and can still improve the better monitoring and management of breast cancer patients. We will discuss the evidences of the use of CTCs as a tool to monitor cancer progression and therapy response, based on the prognostic and predictive value they have, as well as a tool to unravel mechanisms of resistance to therapy and to identify new biomarkers allowing to predict therapy success. Moreover, we will analyse the main aspects of ongoing clinical trials and how they can contribute to determine the clinical utility of CTCs as a breast cancer biomarker. We will also touch upon general knowledge or basic notions of the biology of the metastatic process in epithelial cancers, in order to understand the origin and biology of CTCs. In this sense, we will pay special attention to EMT (epithelial to mesenchymal transition), dormancy and minimal residual disease, three key aspects that determine the outcome of the disease. We will also cover general aspects on the isolation and characterization techniques applies to the study of CTCs, and also the possibilities that the study of CTCs, as a biomarker with biological function, is opening in terms of understanding the biology of metastatic cells and the identification of therapeutic targets based on the functional and molecular characterization of CTCs. Lastly, we will try to foresee the future of CTCs in terms of clinical application and implementation in the clinical routine.